Taiwan FDA registration 869e459c067c7de0c3dbd7baa5ed394d
MagQu Carcinoembryonic Antigen (CEA) Magnetic Reagent
TW: 磁量癌胚抗原磁性試劑
Taiwan·Risk Class 2·MD·MAGQU CO., LTD.·Registered Jul 10, 2017 – Jul 10, 2022ExpiredRegistration details
- Analysis ID
- 869e459c067c7de0c3dbd7baa5ed394d
- License Form
- Ministry of Health Medical Device Manufacturing No. 005625
Company information
- Manufacturer
- MAGQU CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- MAGQU CO., LTD.
Product details
- Intended Use
- This product is used to quantify the concentration of carcinoembryonic antigen (CEA) protein in human serum and needs to be used with a magnetic immunoassay analyzer (XacPro-E series); it can be used to help monitor changes in human serum CEA concentration.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C6010 Tumor-associated antigen immunoassay system
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jul 10, 2017
- Expiry Date
- Jul 10, 2022
About this record
Access comprehensive regulatory information for MagQu Carcinoembryonic Antigen (CEA) Magnetic Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 869e459c067c7de0c3dbd7baa5ed394d and manufactured by MAGQU CO., LTD.. The authorized representative in Taiwan is MAGQU CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices